Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Average Recommendation of "Moderate Buy" from Brokerages

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) has been given an average rating of "Moderate Buy" by the five ratings firms that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year price target among analysts that have covered the stock in the last year is $17.60.

Several brokerages have commented on CCAP. Wells Fargo & Company dropped their price target on Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Friday, May 16th. Keefe, Bruyette & Woods cut shares of Crescent Capital BDC from an "outperform" rating to a "market perform" rating and cut their target price for the company from $18.50 to $17.00 in a research note on Friday, May 16th. Wall Street Zen downgraded shares of Crescent Capital BDC from a "hold" rating to a "sell" rating in a report on Thursday, May 22nd. Finally, Raymond James Financial dropped their price objective on shares of Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating on the stock in a report on Friday, May 16th.

Institutional Investors Weigh In On Crescent Capital BDC

Hedge funds have recently bought and sold shares of the stock. Montag A & Associates Inc. bought a new stake in shares of Crescent Capital BDC in the 4th quarter valued at about $35,000. C M Bidwell & Associates Ltd. acquired a new stake in shares of Crescent Capital BDC in the 4th quarter valued at about $39,000. Aquatic Capital Management LLC bought a new position in shares of Crescent Capital BDC in the fourth quarter valued at $129,000. Generation Capital Management LLC acquired a new position in shares of Crescent Capital BDC during the fourth quarter valued at about $192,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Crescent Capital BDC during the fourth quarter worth about $218,000. 49.46% of the stock is currently owned by institutional investors and hedge funds.

Crescent Capital BDC Price Performance

NASDAQ:CCAP traded up $0.01 during midday trading on Monday, reaching $14.34. The stock had a trading volume of 179,042 shares, compared to its average volume of 142,367. Crescent Capital BDC has a 1-year low of $13.54 and a 1-year high of $20.19. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.09 and a current ratio of 1.09. The firm's fifty day simple moving average is $15.45 and its 200-day simple moving average is $17.54.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a net margin of 26.20% and a return on equity of 11.10%. The business had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. As a group, research analysts anticipate that Crescent Capital BDC will post 2.09 earnings per share for the current year.

Crescent Capital BDC Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.42 per share. The ex-dividend date is Monday, June 30th. This represents a $1.68 annualized dividend and a dividend yield of 11.72%. Crescent Capital BDC's dividend payout ratio is currently 125.37%.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.